Skip to main content
VulnerabilityPublished

CVE-2026-123051: The REV.exe module distributed with Farmasimplex contains embedded OAuth client credentials for

Source GCVE Database

0
Compare
Authoritative record:CVE-2026-123051· Low 1.2

Not known to be exploited · CVSS 1.2 Low : upgrade to 16.2.0 when convenient.

Data as of 17 Nov 2026, 16:51 UTC

CVSS 4.0 base score
1.2Low
How severe the flaw is on the 0–10 CVSS scale.

Thin evidence

One scorer or none
CVSS scores by source
CNA (ENISA)CVSS 4.01.2
Patch
Available – fixed in 16.2.0
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:U

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 17 Nov 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 16 Nov 2026.

What to do

Upgrade Farmasimplex REV.exe to 16.2.0.

Affected software

ProductAffectedFixed in
CIPCarbone srlFarmasimplex REV.exeAffected
  • <16.2.0
Fixed in
  • 16.2.0

AI-suggested

Mitigation should focus on restricting access to the REV.exe executable to trusted users only and implementing additional authentication controls around the OAuth integration to limit the potential misuse of extracted credentials.

Description

The REV.exe module distributed with Farmasimplex contains embedded OAuth client credentials for integration with the IZS platform. An attacker who gains access to this executable could extract these credentials and potentially reuse them to access integration resources or manipulate associated information, depending on the privileges and authentication controls in place. This vulnerability is identified as CVE-2026-123051 and has a medium severity rating.

References

Community reviews

Loading reviews…